Novel polycyclic compounds having the structural formula (I) below:
##STR00001## are formulated into pharmaceutical compositions suited for
administration in human or veterinary medicine (in dermatology, and also
in the fields of cardiovascular diseases, immune diseases and/or diseases
associated with lipid metabolism), or, alternatively, into cosmetic
compositions.